After cash funneling scandal, biotech billionaire Soon-Shiong charges on with Nant IPO
Patrick Soon-Shiong, the biotech billionaire embroiled in scandal last year, is corralling bankers for a new IPO he’s planning to fund an experimental cancer drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.